Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed Aug 7, 2018 · 10-Q · 38 days after period end · 0001280776-18-000079
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$2.67M | -$12.41M | -$9.47M | -$15.11M |
| EPS Diluted | -$3.15 | -$0.29 | -$0.30 | -$0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 7, 2018 · 38 d after period end
